Ohio State Navbar

Sign In

RSS Feed Regenerative Medicine News

BioTime to Produce Stem Cells for Research in Muscle Disorders 


"BioTime's business strategy includes generating near-term revenues in the emerging field of regenerative medicine by bringing some of the most advanced stem cell technologies to the market as research products." Human embryonic stem (hES) cell lines ...Read More.​


Posted on 15-Mar-12 by Geier, Eric
Tags: Science and Industry News
Trackback Url  |  Link to this post | Bookmark this post with: